Chau C Chien, MD
Neurology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 44 years
- Graduated 1982
Offices
1 location
Looking this up.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chien’s office at (415) 876-4030 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A45801 · Current
Licensed to practise in California · since 1989 · expires 2028-12-31 · Autonomous University of Ciudad Juarez School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Neurology
Original Medicare doctor bills
$13,629
Medicare paid this office $13,629 for 73 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 38 | $6,007 | $94 |
| New patient visit (60+ min) | 21 | $4,100 | $195 |
| Short return visit | 23 | $1,602 | $46 |
Who their Medicare patients are
73 Original Medicare patients in 2024. Average age 81 · Under 65 0% · 85 and older 33% · Women 62% · Also on Medicaid 78% · Health risk score 1.64. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 59% · Dementia 36% · Chronic kidney disease 30% · Atrial fibrillation 23% · Depression 23% · Stroke 21% · COPD 18% · Heart failure 15%.
The office billed $27,660, Medicare allowed $20,890 and paid $13,629; for 135 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 73 | 135 | 81 | 1.64 | $27,660 | $13,629 |
| 2023 | 129 | 246 | 80 | 1.37 | $49,490 | $25,436 |
| 2022 | 166 | 348 | 79 | 1.32 | $69,930 | $36,847 |
| 2021 | 168 | 401 | 79 | 1.32 | $91,735 | $43,129 |
| 2020 | 150 | 395 | 79 | 1.55 | $100,260 | $37,158 |
| 2019 | 258 | 616 | 79 | 1.24 | $201,275 | $68,136 |
| 2018 | 278 | 721 | 77 | 1.38 | $244,385 | $80,356 |
| 2017 | 293 | 690 | 77 | 1.39 | $231,940 | $74,132 |
| 2016 | 267 | 636 | 77 | 1.26 | $208,130 | $70,829 |
| 2015 | 295 | 707 | 77 | 1.35 | $195,711 | $74,935 |
| 2014 | 307 | 721 | 77 | 1.22 | $203,681 | $76,947 |
| 2013 | 339 | 818 | 77 | 1.42 | $228,208 | $82,690 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 69 | $10,734 | $101 |
| New patient visit (60+ min) | 18 | $3,406 | $189 |
| Short return visit | 35 | $3,136 | $46 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 11 | $2,720 | $247 |
| New patient visit (45+ min) | 16 | $2,099 | $131 |
2022: 7 services
| Return visit (30+ min) | 92 | $16,334 | $107 |
| New patient visit (45+ min) | 35 | $4,979 | $142 |
| Short return visit | 50 | $3,881 | $46 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 15 | $3,130 | $209 |
| New patient visit (60+ min) | 13 | $2,636 | $203 |
| Long return visit (40+ min) | 15 | $2,361 | $157 |
| Short return visit (20+ min) | 11 | $848 | $77 |
2021: 7 services
| Return visit (30+ min) | 74 | $12,690 | $116 |
| New patient visit (45+ min) | 66 | $10,150 | $154 |
| Short return visit | 55 | $5,537 | $47 |
| Muscle electrical test | 19 | $4,000 | $105 |
| Nerve test | 19 | $3,617 | $190 |
| Long return visit (40+ min) | 15 | $2,270 | $151 |
| Short return visit (20+ min) | 20 | $2,155 | $86 |
2020: 6 services
| Return visit (30+ min) | 79 | $9,966 | $88 |
| New patient visit (45+ min) | 52 | $7,703 | $148 |
| Muscle electrical test | 27 | $5,773 | $100 |
| Nerve test | 27 | $5,537 | $191 |
| Short return visit | 47 | $4,189 | $40 |
| Short return visit (20+ min) | 23 | $1,546 | $64 |
2019: 6 services
| Return visit (30+ min) | 133 | $20,338 | $90 |
| New patient visit (45+ min) | 126 | $16,997 | $135 |
| Nerve test | 65 | $12,885 | $181 |
| Muscle electrical test | 65 | $12,710 | $90 |
| New patient visit (60+ min) | 13 | $2,214 | $170 |
| Short return visit (20+ min) | 25 | $1,629 | $63 |
2018: 6 services
| New patient visit (45+ min) | 140 | $20,084 | $143 |
| Return visit (30+ min) | 140 | $18,895 | $90 |
| Nerve test | 90 | $17,493 | $188 |
| Muscle electrical test | 90 | $16,180 | $87 |
| Short return visit (20+ min) | 50 | $4,291 | $65 |
| Long return visit (40+ min) | 11 | $1,394 | $127 |
2017: 5 services
| New patient visit (45+ min) | 154 | $20,507 | $133 |
| Return visit (30+ min) | 137 | $16,934 | $84 |
| Nerve test | 81 | $15,382 | $181 |
| Muscle electrical test | 81 | $14,365 | $85 |
| Short return visit (20+ min) | 36 | $2,933 | $60 |
2016: 5 services
| New patient visit (45+ min) | 140 | $20,464 | $146 |
| Return visit (30+ min) | 139 | $17,120 | $91 |
| Nerve test | 71 | $13,717 | $188 |
| Muscle electrical test | 73 | $13,526 | $90 |
| Short return visit (20+ min) | 44 | $4,072 | $67 |
2015: 6 services
| New patient visit (45+ min) | 149 | $22,081 | $148 |
| Return visit (30+ min) | 163 | $17,605 | $90 |
| Short return visit (20+ min) | 99 | $12,218 | $68 |
| Muscle electrical test | 51 | $9,573 | $90 |
| Nerve test | 46 | $9,155 | $191 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,971 | $179 |
2014: 6 services
| New patient visit (45+ min) | 150 | $22,614 | $151 |
| Return visit (30+ min) | 154 | $16,692 | $96 |
| Short return visit (20+ min) | 104 | $13,091 | $69 |
| Muscle electrical test | 56 | $10,190 | $91 |
| Nerve test | 54 | $9,750 | $181 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,987 | $181 |
2013: 5 services
| New patient visit (45+ min) | 153 | $22,401 | $146 |
| Return visit (30+ min) | 183 | $18,713 | $93 |
| Short return visit (20+ min) | 120 | $15,337 | $67 |
| Nerve test | 59 | $10,746 | $176 |
| Muscle electrical test | 63 | $10,412 | $83 |
Drugs they prescribed that Part D paid
$40,293
Pharmacies billed $40,293 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
699 generic and 21 brand-name prescriptions · $40,293 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Carbidopa-Levodopa-Entacapone | 12 | $6,566 | $547 |
| Memantine Hcl Er | 11 | $5,573 | $507 |
| Carbidopa-Levodopa Er | 84 | $4,878 | $58 |
| Memantine | 245 | $3,915 | $16 |
| Selegiline | 22 | $1,970 | $90 |
See all 14 drugs
| Carbidopa-Levodopa-Entacapone | 12 | $6,566 | $547 |
| Memantine Hcl Er | 11 | $5,573 | $507 |
| Carbidopa-Levodopa Er | 84 | $4,878 | $58 |
| Memantine | 245 | $3,915 | $16 |
| Selegiline | 22 | $1,970 | $90 |
| Levetiracetam | 45 | $1,687 | $37 |
| Quetiapine | 17 | $962 | $57 |
| Gabapentin | 99 | $931 | $9 |
| Carbidopa-Levodopa | 24 | $564 | $24 |
| Pramipexole Dihydrochloride | 13 | $329 | $25 |
| Propranolol | 19 | $313 | $16 |
| Trazodone | 16 | $272 | $17 |
| Donepezil | 20 | $116 | $6 |
| Meclizine | 14 | $42 | $3 |
Year by year
| 2024 | 720 | 227 | None | 3% | $40,293 |
| 2023 | 898 | 273 | None | 2% | $79,653 |
| 2022 | 1,012 | 282 | None | 3% | $91,643 |
| 2021 | 1,123 | 327 | None | 2% | $88,000 |
| 2020 | 1,262 | 282 | 1% (15) | 2% | $116,231 |
| 2019 | 1,432 | 336 | None | 6% | $149,921 |
| 2018 | 1,634 | 342 | 0% (0) | 6% | $127,802 |
| 2017 | 1,589 | 329 | 0% (0) | 6% | $111,719 |
| 2016 | 1,891 | 377 | 0% (0) | None | $136,514 |
| 2015 | 2,400 | 440 | 0% (0) | None | $192,403 |
| 2014 | 2,561 | 416 | 0% (0) | None | $226,274 |
| 2013 | 2,702 | 472 | 0% (0) | 21% | $217,194 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Carbidopa-Levodopa Er | 97 | $10,980 | $113 |
| Memantine | 240 | $10,878 | $45 |
| Memantine Hcl Er | 14 | $9,509 | $679 |
| Carbidopa-Levodopa-Entacapone | 14 | $8,425 | $602 |
| Aspirin-Dipyridamole Er | 24 | $7,479 | $312 |
| Levetiracetam | 60 | $4,299 | $72 |
| Selegiline | 24 | $3,286 | $137 |
| Gabapentin | 152 | $2,932 | $19 |
| Pregabalin | 14 | $2,541 | $181 |
| Carbidopa-Levodopa | 33 | $1,816 | $55 |
| Quetiapine | 12 | $1,597 | $133 |
| Propranolol | 31 | $1,062 | $34 |
| Pramipexole Dihydrochloride | 18 | $463 | $26 |
| Clopidogrel | 15 | $326 | $22 |
| Trazodone | 19 | $273 | $14 |
| Primidone | 14 | $145 | $10 |
| Meclizine | 17 | $137 | $8 |
2022: 19 drugs
| Carbidopa-Levodopa Er | 108 | $16,954 | $157 |
| Memantine | 252 | $11,706 | $46 |
| Carbidopa-Levodopa-Entacapone | 21 | $10,718 | $510 |
| Memantine Hcl Er | 17 | $8,575 | $504 |
| Aspirin-Dipyridamole Er | 30 | $5,430 | $181 |
| Carbidopa-Levodopa | 38 | $4,783 | $126 |
| Selegiline | 29 | $4,327 | $149 |
| Levetiracetam | 63 | $2,827 | $45 |
| Quetiapine | 31 | $1,903 | $61 |
| Gabapentin | 150 | $1,722 | $11 |
| Pregabalin | 15 | $1,243 | $83 |
| Enulose | 12 | $614 | $51 |
| Lactulose | 13 | $588 | $45 |
| Propranolol | 20 | $537 | $27 |
| Pramipexole Dihydrochloride | 18 | $516 | $29 |
| Clopidogrel | 19 | $319 | $17 |
| Trazodone | 21 | $167 | $8 |
| Meclizine | 20 | $155 | $8 |
| Primidone | 21 | $112 | $5 |
2021: 18 drugs
| Carbidopa-Levodopa Er | 136 | $16,669 | $123 |
| Aspirin-Dipyridamole Er | 31 | $11,029 | $356 |
| Memantine | 208 | $9,005 | $43 |
| Memantine Hcl Er | 21 | $8,949 | $426 |
| Carbidopa-Levodopa-Entacapone | 12 | $6,958 | $580 |
| Selegiline | 37 | $5,025 | $136 |
| Levetiracetam | 69 | $3,316 | $48 |
| Carbidopa-Levodopa | 36 | $2,432 | $68 |
| Gabapentin | 247 | $2,018 | $8 |
| Pregabalin | 19 | $1,558 | $82 |
| Quetiapine | 44 | $1,315 | $30 |
| Propranolol | 29 | $650 | $22 |
| Pramipexole Dihydrochloride | 15 | $523 | $35 |
| Clopidogrel | 19 | $225 | $12 |
| Trazodone | 30 | $203 | $7 |
| Meclizine | 18 | $150 | $8 |
| Primidone | 17 | $110 | $6 |
| Sertraline | 12 | $93 | $8 |
2020: 23 drugs
| Carbidopa-Levodopa Er | 176 | $20,689 | $118 |
| Aspirin-Dipyridamole Er | 41 | $19,536 | $476 |
| Memantine Hcl Er | 39 | $16,400 | $421 |
| Rasagiline Mesylate | 16 | $12,045 | $753 |
| Carbidopa-Levodopa-Entacapone | 12 | $9,158 | $763 |
| Memantine | 189 | $7,939 | $42 |
| Selegiline | 47 | $6,680 | $142 |
| Pregabalin | 29 | $2,229 | $77 |
| Levetiracetam | 63 | $2,228 | $35 |
| Gabapentin | 239 | $1,901 | $8 |
| Oxcarbazepine | 16 | $995 | $62 |
| Carbidopa-Levodopa | 34 | $966 | $28 |
| Quetiapine | 64 | $959 | $15 |
| Pramipexole Dihydrochloride | 27 | $788 | $29 |
| Propranolol | 33 | $545 | $17 |
| Lactulose | 12 | $281 | $23 |
| Clopidogrel | 29 | $259 | $9 |
| Paroxetine | 18 | $191 | $11 |
| Meclizine | 22 | $148 | $7 |
| Trazodone | 20 | $121 | $6 |
| Alprazolam | 12 | $95 | $8 |
| Primidone | 17 | $74 | $4 |
| Tramadol | 15 | $48 | $3 |
2019: 24 drugs
| Carbidopa-Levodopa Er | 197 | $21,346 | $108 |
| Memantine | 216 | $20,726 | $96 |
| Lyrica | 30 | $19,658 | $655 |
| Neupro | 22 | $14,280 | $649 |
| Memantine Hcl Er | 28 | $12,766 | $456 |
| Aspirin-Dipyridamole Er | 25 | $11,528 | $461 |
| Selegiline | 69 | $8,993 | $130 |
| Carbidopa-Levodopa-Entacapone | 16 | $5,100 | $319 |
| Gabapentin | 295 | $2,829 | $10 |
| Quetiapine | 59 | $1,893 | $32 |
| Levetiracetam | 59 | $1,686 | $29 |
| Pramipexole Dihydrochloride | 33 | $1,535 | $47 |
| Pregabalin | 15 | $1,407 | $94 |
| Carbidopa-Levodopa | 31 | $1,352 | $44 |
| Propranolol | 59 | $1,271 | $22 |
| Clopidogrel | 19 | $400 | $21 |
| Oxcarbazepine | 13 | $386 | $30 |
| Meclizine | 49 | $332 | $7 |
| Lactulose | 11 | $265 | $24 |
| Primidone | 25 | $261 | $10 |
| Paroxetine | 23 | $252 | $11 |
| Trazodone | 24 | $156 | $6 |
| Donepezil | 14 | $139 | $10 |
| Alprazolam | 14 | $91 | $7 |
2018: 21 drugs
| Lyrica | 41 | $24,858 | $606 |
| Carbidopa-Levodopa Er | 259 | $21,003 | $81 |
| Memantine | 193 | $14,048 | $73 |
| Selegiline | 108 | $11,764 | $109 |
| Aggrenox | 14 | $11,647 | $832 |
| Neupro | 16 | $10,046 | $628 |
| Gabapentin | 377 | $2,492 | $7 |
| Memantine Hcl Er | 13 | $2,337 | $180 |
| Levetiracetam | 76 | $1,604 | $21 |
| Quetiapine | 54 | $1,420 | $26 |
| Propranolol | 67 | $1,213 | $18 |
| Pramipexole Dihydrochloride | 43 | $1,118 | $26 |
| Carbidopa-Levodopa | 31 | $917 | $30 |
| Oxcarbazepine | 15 | $429 | $29 |
| Cilostazol | 17 | $391 | $23 |
| Trazodone | 36 | $354 | $10 |
| Meclizine | 57 | $338 | $6 |
| Donepezil | 37 | $294 | $8 |
| Primidone | 24 | $267 | $11 |
| Clopidogrel | 20 | $196 | $10 |
| Alprazolam | 15 | $70 | $5 |
2017: 24 drugs
| Lyrica | 29 | $16,224 | $559 |
| Carbidopa-Levodopa Er | 247 | $15,696 | $64 |
| Selegiline | 132 | $12,563 | $95 |
| Memantine | 175 | $9,724 | $56 |
| Aggrenox | 15 | $9,542 | $636 |
| Namenda Xr | 13 | $5,140 | $395 |
| Lidocaine | 14 | $4,723 | $337 |
| Gabapentin | 390 | $2,858 | $7 |
| Levetiracetam | 71 | $1,205 | $17 |
| Pramipexole Dihydrochloride | 48 | $1,134 | $24 |
| Propranolol | 50 | $787 | $16 |
| Carbidopa-Levodopa | 21 | $591 | $28 |
| Quetiapine | 58 | $586 | $10 |
| Primidone | 34 | $493 | $15 |
| Oxcarbazepine | 16 | $482 | $30 |
| Trazodone | 40 | $362 | $9 |
| Lamotrigine | 11 | $332 | $30 |
| Clopidogrel | 24 | $212 | $9 |
| Donepezil | 35 | $205 | $6 |
| Cilostazol | 16 | $194 | $12 |
| Amitriptyline | 11 | $158 | $14 |
| Lactulose | 11 | $146 | $13 |
| Meclizine | 27 | $133 | $5 |
| Alprazolam | 14 | $69 | $5 |
2016: 25 drugs
| Carbidopa-Levodopa Er | 335 | $22,232 | $66 |
| Selegiline | 187 | $18,185 | $97 |
| Aggrenox | 22 | $18,111 | $823 |
| Lidocaine | 50 | $9,583 | $192 |
| Memantine | 160 | $7,851 | $49 |
| Lyrica | 14 | $7,358 | $526 |
| Aspirin-Dipyridamole Er | 15 | $7,174 | $478 |
| Gabapentin | 380 | $2,155 | $6 |
| Levetiracetam | 96 | $1,942 | $20 |
| Pramipexole Dihydrochloride | 53 | $1,811 | $34 |
| Quetiapine | 96 | $1,565 | $16 |
| Pyridostigmine | 11 | $865 | $79 |
| Donepezil | 87 | $726 | $8 |
| Propranolol Hcl Er | 12 | $572 | $48 |
| Propranolol | 33 | $523 | $16 |
| Carbidopa-Levodopa | 20 | $408 | $20 |
| Trazodone | 45 | $382 | $8 |
| Primidone | 34 | $371 | $11 |
| Oxcarbazepine | 13 | $328 | $25 |
| Cilostazol | 18 | $316 | $18 |
| Lactulose | 17 | $192 | $11 |
| Meclizine | 35 | $190 | $5 |
| Clopidogrel | 20 | $178 | $9 |
| Amitriptyline | 13 | $104 | $8 |
| Alprazolam | 11 | $58 | $5 |
2015: 29 drugs
| Aggrenox | 52 | $35,942 | $691 |
| Namenda | 107 | $34,863 | $326 |
| Carbidopa-Levodopa Er | 472 | $29,634 | $63 |
| Selegiline | 227 | $20,638 | $91 |
| Lyrica | 21 | $9,931 | $473 |
| Azilect | 16 | $8,592 | $537 |
| Lidocaine | 20 | $5,151 | $258 |
| Memantine | 67 | $4,307 | $64 |
| Gabapentin | 494 | $3,052 | $6 |
| Levetiracetam | 115 | $2,488 | $22 |
| Quetiapine | 108 | $1,783 | $17 |
| Donepezil | 136 | $1,604 | $12 |
| Pramipexole Dihydrochloride | 40 | $1,455 | $36 |
| Pyridostigmine | 23 | $1,274 | $55 |
| Carbidopa-Levodopa | 29 | $659 | $23 |
| Propranolol Hcl Er | 12 | $575 | $48 |
| Propranolol | 53 | $523 | $10 |
| Primidone | 37 | $445 | $12 |
| Oxcarbazepine | 14 | $405 | $29 |
| Cilostazol | 22 | $371 | $17 |
| Clopidogrel | 35 | $350 | $10 |
| Trazodone | 54 | $330 | $6 |
| Meclizine | 45 | $321 | $7 |
| Pentoxifylline | 14 | $252 | $18 |
| Prednisone | 11 | $127 | $12 |
| Amitriptyline | 11 | $88 | $8 |
| Trihexyphenidyl | 15 | $72 | $5 |
| Sertraline | 14 | $71 | $5 |
| Alprazolam | 12 | $65 | $5 |
2014: 31 drugs
| Namenda | 244 | $71,353 | $292 |
| Aggrenox | 65 | $30,756 | $473 |
| Carbidopa-Levodopa Er | 466 | $26,528 | $57 |
| Selegiline | 265 | $23,426 | $88 |
| Keppra | 16 | $16,502 | $1,031 |
| Azilect | 24 | $15,191 | $633 |
| Lyrica | 23 | $9,122 | $397 |
| Lamictal | 11 | $5,731 | $521 |
| Gabapentin | 549 | $3,804 | $7 |
| Quetiapine | 107 | $3,723 | $35 |
| Levetiracetam | 105 | $2,737 | $26 |
| Pramipexole Dihydrochloride | 43 | $2,034 | $47 |
| Pyridostigmine | 30 | $1,463 | $49 |
| Donepezil | 103 | $1,256 | $12 |
| Propranolol Hcl Er | 17 | $749 | $44 |
| Primidone | 44 | $680 | $15 |
| Lidocaine | 11 | $611 | $56 |
| Oxcarbazepine | 13 | $445 | $34 |
| Clopidogrel | 27 | $433 | $16 |
| Cilostazol | 31 | $424 | $14 |
| Carbidopa-Levodopa | 14 | $377 | $27 |
| Trazodone | 44 | $322 | $7 |
| Meclizine | 33 | $290 | $9 |
| Propranolol | 56 | $260 | $5 |
| Generlac | 14 | $233 | $17 |
| Lactulose | 12 | $224 | $19 |
| Prednisone | 13 | $150 | $12 |
| Alprazolam | 13 | $92 | $7 |
| Trihexyphenidyl | 14 | $83 | $6 |
| Clonazepam | 14 | $81 | $6 |
| Sertraline | 13 | $74 | $6 |
2013: 32 drugs
| Namenda | 232 | $64,678 | $279 |
| Selegiline | 273 | $25,665 | $94 |
| Carbidopa-Levodopa Er | 438 | $25,387 | $58 |
| Aggrenox | 62 | $20,937 | $338 |
| Keppra | 16 | $15,048 | $940 |
| Azilect | 31 | $13,983 | $451 |
| Lyrica | 36 | $11,031 | $306 |
| Quetiapine | 78 | $5,483 | $70 |
| Gabapentin | 648 | $4,939 | $8 |
| Levetiracetam | 139 | $3,944 | $28 |
| Carbidopa-Levodopa-Entacapone | 12 | $3,228 | $269 |
| Pramipexole Dihydrochloride | 54 | $2,700 | $50 |
| Clopidogrel | 27 | $2,002 | $74 |
| Donepezil | 75 | $1,483 | $20 |
| Pyridostigmine | 27 | $1,125 | $42 |
| Primidone | 56 | $925 | $17 |
| Carbidopa-Levodopa | 30 | $918 | $31 |
| Cilostazol | 39 | $647 | $17 |
| Propranolol | 65 | $635 | $10 |
| Pentoxifylline | 22 | $522 | $24 |
| Dipyridamole | 11 | $403 | $37 |
| Fluvoxamine Maleate | 12 | $282 | $23 |
| Lactulose | 13 | $258 | $20 |
| Trazodone | 36 | $246 | $7 |
| Meclizine | 27 | $240 | $9 |
| Trihexyphenidyl | 31 | $222 | $7 |
| Lamotrigine | 11 | $210 | $19 |
| Sertraline | 17 | $141 | $8 |
| Alprazolam | 18 | $116 | $6 |
| Clonazepam | 17 | $112 | $7 |
| Prednisone | 13 | $67 | $5 |
| Amitriptyline | 11 | $30 | $3 |
Money from drug and device companies
$72 in 2019
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $72 | 1 payment
|
See the published payment
| Janssen Pharmaceuticals | Meals · 2019-10-02 | Xarelto | $72 |
Professional record
- NPI
- 1578503462
- Licence
- CA A45801California A45801: Current · expires 2028-12-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 3115 Geary Blvd, San Francisco, CA, 94118
- NPI first listed
- 2006-06-07
- NPI last updated
- 2017-10-11
This is when the NPI record was last certified, not a medical board exam.